Immune Therapy News Today

what i have done is follow a process which is the right process. integrity is really important to me. the kremlin has dismissed as a lie a claim by a borisjohnson that he was threatened by vladimir putin, before the russian invasion of ukraine. and new research suggest uk bosses are reluctant to hire over 50s, preferring younger workers. in the last hour it is been announced that firefighters are across the uk have voted to go on strike. it will be there. walk out in 20 years following...

Expert oncologists discuss the challenges and considerations in choosing second-line therapy for a patient with metastatic renal cell carcinoma (RCC) in a case-based context.

Further understanding of the cancer immunity cycle could drive the development of novel immune therapies for patients with renal cell carcinoma.

Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Marburg Vaccine in Uganda

MinervaX Raises EUR 54M in Upsized Financing to Advance the Development of its Maternal Vaccine Against Group B Streptococcus

/PRNewswire/ -- Allied Market Research published a report, titled, "Lymphoma therapeutics Market by Disease Type (Hodgkin Lymphoma and Non-Hodgkin Lymphoma),...

Lori A. Leslie, MD, an expert on CLL, talks about factors that influence treatment decisions.

Potential treatments is progressing in leaps and bounds. absolutely. as a result of the _ in leaps and bounds. absolutely. as a result of the research _ in leaps and bounds. absolutely. as a result of the research that - in leaps and bounds. absolutely. as a result of the research that we - in leaps and bounds. absolutely. as a result of the research that we and | a result of the research that we and others have done over the last a0 years, we have doubled the survival of patients receiving at t...

Sabin Vaccine Institute Receives $35 Million from BARDA with Potential of up to $214 Million for Ebola Sudan and Marburg Vaccines

Takeda’s QDENGA (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union